Based on recent data, Connect Biopharma Holdings Limited (CNTB) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of -30.05M. Its average trading volume over the past 3 months is 277.41K, indicating liquidity. These fundamental metrics provide insight into CNTB's underlying financial health and market activity.
| ATR | 0.21 |
| Enterprise Value | -30.05M |
| Avg Vol (3 Months) | 277.41K |
| Avg Vol (10 Days) | 55.01K |
Connect Biopharma Holdings Limited (CNTB) technical indicators as of January 11, 2026: the SMA 20 is -12.39%, SMA 50 at -7.72%, and SMA 200 at 36.11%. The RSI 14 value is 39.94, suggesting its current momentum. These technical analysis signals help assess CNTB's price trends and potential future movements.
| SMA 20 | -12.39% |
| SMA 50 | -7.72% |
| SMA 200 | 36.11% |
| RSI 14 | 39.94 |
Connect Biopharma Holdings Limited (CNTB) stock performance overview as of January 11, 2026: The 52-week high is $3.28 (currently -34.45% below), and the 52-week low is $0.51 (currently 321.57% above). Over the past year, CNTB's performance is 84.3%, compared to the S&P 500's 12.34% change.
| 52-Week High | 3.28 |
| 52-Week High Chg | -34.45% |
| 52-Week Low | 0.51 |
| 52-Week Low Chg | +321.57% |
| S&P 500 52-Week Chg | 12.34% |
According to market data, Connect Biopharma Holdings Limited (CNTB) stock's recent performance metrics show that over the last month, CNTB is -7.08%, with a Year-to-Date (YTD) performance of -20.92%. Over the past year, the stock has seen a 84.3% change. These figures summarize CNTB's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.52 | 2.89 | 3.28 | 3.28 | 3.28 | 2.83 |
| Low | 2.14 | 2.03 | 1.46 | 1.11 | 0.51 | 2.14 |
| Performance | -20.92% | -7.08% | +25.28% | +104.59% | +84.30% | -20.92% |
According to current financial data, CNTB stock's P/E (TTM) ratio is -3.30, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CNTB, including P/S (61.32), P/B (1.67), and P/FCF (-4.18), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CNTB | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.3 | -1.24 | -5.16 | 32.59 |
| P/S (TTM) | 61.32 | 3.71 | 465.9 | 5.98 |
| P/B (TTM) | 1.67 | 22.78 | -335.2 | 6.24 |
| P/FCF (TTM) | -4.18 | -1756.93 | -394.53 | 36.55 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep